Compare Alcon AG (ALC) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alcon AG vs Nuwellis Inc — how do they compare? Alcon AG trades at $72.42 (market cap $36.44B), while Nuwellis Inc trades at $1.49 (market cap $542.80K). The key difference: Alcon AG is far larger — about 67133.4× Nuwellis Inc's market cap, and Alcon AG pays a 0.48% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| ALC | NUWE | |
|---|---|---|
Market Cap | $36.44B | $542.80K |
Sector | Health | Technology |
52-Week High | $90.12 | $220.50 |
52-Week Low | $62.02 | $1.42 |
Enterprise Value | $40.28B | -$1.27M |
Dividend Yield | 0.48% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
